Nucleo Research
PrivateLast Round
Seed
Nov 1, 2025
Est. Valuation
$1.79M
Total Funding Raised
$4.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nucleo Research operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in November 2025.
Nucleo Research is a healthcare technology company that develops an AI-powered platform to help oncologists and radiologists extract insights from CT scans to support tumor characterization and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleo Research Comparables
Compare Nucleo Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Onc.AI | 83% | |
| Voronoi Health Analytics | 79% | |
| iAID Inc. | 78% |
For institutional investors. Book with your work email.
Nucleo Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Accelerator | Sep 1, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nucleo Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Seed, Accelerator |
| Milhouse Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
$4M round with Milhouse Ventures and Y Combinator.
- Sep 1, 2025
$500K round led by Y Combinator.
For institutional investors. Book with your work email.
Nucleo Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nucleo Research's valuation, stock price, and market status.
Is Nucleo Research a public or private company?
Nucleo Research is a private company.
What is the current stock price of Nucleo Research?
Nucleo Research is a private company, so its shares have no public market price. Caplight tracks Nucleo Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nucleo Research worth (valuation)?
Nucleo Research's valuation is estimated at $1.8M based on funding round data.
Can I buy Nucleo Research stock?
Nucleo Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nucleo Research's last funding round?
Nucleo Research's most recent funding round was Seed on November 1, 2025.
Who are the main investors in Nucleo Research?
Key investors in Nucleo Research include Y Combinator.
Will Nucleo Research IPO soon?
No public IPO plans have been announced for Nucleo Research.
How can I track Nucleo Research secondary market activity?
Caplight tracks bids, offers, and trades in Nucleo Research's shares on secondary markets.